Press releases
10/02/26
Racine a accompagné le Groupe PAREF dans la cession de sa filiale SOLIA Paref
Concerned lawyers :
Press releases
Our other news
RSE
29/01/26
Racine a accompagné Izili et son actionnaire majoritaire BioLite dans l’acquisition à 100 % de Qotto
Read more
Press releases
23/12/25
Racine advises the majority shareholders of the Malherbe Group on a strategic transaction with Géodis
Paris, 23 December 2025 – Racine advises the majority shareholders of the Malherbe Group on their proposed sale to Geodis.
Having advised the Malherbe Group on several external growth transactions in recent years in France and internationally — including the acquisitions of Normatrans (2022),...
Read more
Press releases
5/01/26
Racine invests in its talents: Philippe Johnston appointed partner
Paris, 5 January 2026 – Philippe Johnston has been appointed as a partner in the Real Estate department at Racine. This internal promotion, effective from 1 January 2026, reflects Racine’s ongoing commitment to developing talent and strengthening its core practices.
Philippe Johnston has...
Read more
Press releases
8/01/26
Racine advises NanoXplore on a raising €20 million fundrising from MBDA and Bpifrance
Paris, 8 January 2025 – Racine advised NanoXplore, a company specialising in electronics for the space industry, on raising €20 million from MBDA and the Defence Innovation Fund, which is managed by Bpifrance. This strategic investment will enable NanoXplore to accelerate its diversification...
Read more
Press releases
6/01/26
Racine advises Groupe Axtom on its acquisition of Foncières & Territoires
Paris, 6 January 2026 – Racine advised Groupe Axtom, a specialist in commercial real estate and regional development, on its acquisition of a 56% stake in Foncières & Territoires, a management company.
Axtom is a recognised player in the commercial property sector. It operates in several...
Read more
Press releases
5/12/25
Racine advises HealthCare Royalty on its strategic agreement with Nanobiotix
Paris, 5 December 2025 – Racine advised HealthCare Royalty (HCRx), a leading biopharmaceutical financing company, in connection with the signing of a non-dilutive royalty financing agreement with Nanobiotix worth up to US$71 million.
HealthCare Royalty (HCRx) is a leading player in...
Read more